1988
DOI: 10.1007/bf02166769
|View full text |Cite
|
Sign up to set email alerts
|

The preparation of99mTc-labelled methionine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1996
1996
1996
1996

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 2 publications
0
2
0
Order By: Relevance
“…The labelling procedures used are common in nuclear medicine, thus only slight modifications were used as compared to others (Volkert et al, 1982;Mi.inze et al, 1983;Chilton and Thrall, 1990;Ozker et al, 1988Ozker et al, , 1992. 99mTc-diethylenetriaminepentacetic acid (DTPA) was synthesised at room temperature by the addition of 0.1 mL of the SnC1 2 stock solution to 2 mL of an aqueous solution containing 1.7 mL 99mTc0 4 -eluate (10 nmol L-1 ), 0.1 mL 2-morpholinoethanesulfonic acid (MES)-buffer (0.3 mol L-1) pH 5.2 and 0.1 mL DTPA calcium trisodium (0.2 mol L-1 ) pH 5.2.…”
Section: Labelling Proceduresmentioning
confidence: 99%
See 1 more Smart Citation
“…The labelling procedures used are common in nuclear medicine, thus only slight modifications were used as compared to others (Volkert et al, 1982;Mi.inze et al, 1983;Chilton and Thrall, 1990;Ozker et al, 1988Ozker et al, , 1992. 99mTc-diethylenetriaminepentacetic acid (DTPA) was synthesised at room temperature by the addition of 0.1 mL of the SnC1 2 stock solution to 2 mL of an aqueous solution containing 1.7 mL 99mTc0 4 -eluate (10 nmol L-1 ), 0.1 mL 2-morpholinoethanesulfonic acid (MES)-buffer (0.3 mol L-1) pH 5.2 and 0.1 mL DTPA calcium trisodium (0.2 mol L-1 ) pH 5.2.…”
Section: Labelling Proceduresmentioning
confidence: 99%
“…99mTc-DTPA was chosen because of both its kinetic stability and its application in an earlier and comparable study (Harms et al, 1996a). The third marker species, 99mTc-citrate, was used because: ( 1) Tc-citrate is a well-known, relative unstable Tc-species used in ligand-exchange labelling procedures ofradiopharmaceuticals; (2) citrate is a wellknown metal complexing ligand; and ( 3) citrate is present in plant materials and in xylem sap in relative high concentrations and has been reported as a component in metal-translocating complexes (Tiffin, 1972;White et al, 1981;Volkert et al, 1982;DePamphilis eta/., 1983;Ozker et al, 1988;El-Kolaly and El-Wetery, 1990;Ozker et al, 1992).…”
mentioning
confidence: 99%